BIODETEGO

biodetego-logo

BioDetego is developing, VASPfore, a new biomarker test for selecting cancer treatment protocols. The VASP marker provides information that will direct chemotherapy to high risk patients who will likely benefit from treatment while preventing costly and harmful treatment of low risk patients. BioDetego predicts that the VASPfore will provide payors enormous savings (>$150MM/year) by reducing total treatment costs. The company is led by David Zuzga, Ph.D., Founder and CEO, a research scientist with expertise in cell and molecular biology at La Salle University & Giovanni M. Pitari, M.D., Ph.D. Founder and CSO, a physician and research scientist with expertise in Translational Oncology.

#People #Financial #Website #More

BIODETEGO

Industry:
Biotechnology Clinical Trials Health Diagnostics

Founded:
2012-01-01

Address:
Philadelphia, Pennsylvania, United States

Country:
United States

Website Url:
http://www.biodetego.com

Total Employee:
1+

Status:
Active

Total Funding:
50 K USD

Technology used in webpage:
Google Apps For Business Pound Sterling Japanese Yen Wix Wix DNS


Founder


not_available_image

David Zuzga

giovanni-pitari_image

Giovanni Pitari

Investors List

bioadvance_image

BioAdvance

BioAdvance investment in Seed Round - BioDetego

ben-franklin-technology-partners-of-southeastern-pennsylvania_image

Ben Franklin Technology Partners of Southeastern Pennsylvania

Ben Franklin Technology Partners of Southeastern Pennsylvania investment in Seed Round - BioDetego

Official Site Inspections

http://www.biodetego.com Semrush global rank: 4.56 M Semrush visits lastest month: 910

  • Host name: unalocated.63.wixsite.com
  • IP address: 185.230.63.171
  • Location: Ashburn United States
  • Latitude: 39.018
  • Longitude: -77.539
  • Metro Code: 511
  • Timezone: America/New_York
  • Postal: 20147

Loading ...

More informations about "BioDetego" on Search Engine